Want to see JP:6823 full AI Analyst Report?
Top Page
Rion Co., Ltd.
(6823)
Select Model
Select Model
Rating:78Outperform
Price Target:
¥3,922.00
▲(45.75% Upside)
Action:Reiterated
Date:08/06/26
The score is driven primarily by strong financial performance (consistent growth, improving earnings, and a very low-debt balance sheet). Valuation is also supportive with a low P/E and a solid dividend yield. The main constraint is mixed technical momentum, with negative MACD and the price below the 50-day average despite longer-term trend support.
Positive Factors
Very conservative balance sheet
Near-zero debt and consistent equity compounding provide durable financial flexibility. Low leverage reduces refinancing and interest-rate risk, supports capital allocation for R&D, dividends or opportunistic M&A, and strengthens resilience through economic cycles.
Negative Factors
Volatile free cash flow
Significant FCF swings suggest working-capital or investment timing variability, complicating multi-period planning. Persistent volatility can strain liquidity in weak years and makes predictable capital returns or sustained reinvestment programs harder to guarantee.
Read all positive and negative factors
Positive Factors
Negative Factors
Very conservative balance sheet
Near-zero debt and consistent equity compounding provide durable financial flexibility. Low leverage reduces refinancing and interest-rate risk, supports capital allocation for R&D, dividends or opportunistic M&A, and strengthens resilience through economic cycles.
Read all positive factors
Rion Co., Ltd. (6823) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥41.06B
Dividend Yield2.55%
Average Volume (3M)26.46K
Price to Earnings (P/E)11.9
Beta (1Y)1.08
Revenue Growth2.15%
EPS Growth12.47%
CountryJP
Employees1,003
SectorGeneral
Sector StrengthN/A
IndustryMedical - Specialties
Share Statistics
EPS (TTM)271.40
Shares Outstanding12,347,700
10 Day Avg. Volume21,140
30 Day Avg. Volume26,463
Financial Highlights & Ratios
PEG Ratio0.59
Price to Book (P/B)0.96
Price to Sales (P/S)1.17
P/FCF Ratio9.38
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)283.9
Revenue Forecast (FY)¥29.70B
Rion Co., Ltd. Business Overview & Revenue Model
Company Description
Rion Co., Ltd. develops, manufactures, sells, and services particle counters, medical equipment, and environmental equipment in Japan. The company’s audiological equipment includes hearing instruments, such as analog and digital BTE, trimmer digit...
How the Company Makes Money
Rion makes money primarily through the sale of its proprietary hardware products and related solutions in two main areas: (1) Measurement/industrial instrumentation and (2) hearing/medical devices. In its measurement business, revenue is generated...
Rion Co., Ltd. Financial Statement Overview
Summary
Income Statement
83
Very Positive
Balance Sheet
92
Very Positive
Cash Flow
78
Positive
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 28.50B | 27.88B | 25.73B | 23.87B | 22.64B |
| Gross Profit | 13.98B | 15.35B | 14.33B | 12.69B | 12.22B |
| EBITDA | 5.78B | 5.14B | 4.42B | 3.13B | 3.89B |
| Net Income | 3.35B | 2.86B | 2.65B | 1.80B | 2.23B |
Balance Sheet | |||||
| Total Assets | 41.78B | 39.13B | 37.40B | 34.81B | 33.42B |
| Cash, Cash Equivalents and Short-Term Investments | 8.56B | 6.01B | 5.03B | 5.37B | 7.72B |
| Total Debt | 0.00 | 11.73M | 21.88M | 28.46M | 40.07M |
| Total Liabilities | 6.98B | 7.70B | 8.19B | 8.20B | 8.14B |
| Stockholders Equity | 34.80B | 31.44B | 29.21B | 26.61B | 25.29B |
Cash Flow | |||||
| Free Cash Flow | 3.56B | 2.14B | 725.98M | 473.30M | 2.31B |
| Operating Cash Flow | 4.17B | 3.44B | 2.86B | 1.78B | 2.84B |
| Investing Cash Flow | -753.08M | -1.69B | -2.65B | -3.25B | -951.93M |
| Financing Cash Flow | -954.63M | -748.84M | -565.55M | -577.32M | -541.83M |
Rion Co., Ltd. Technical Analysis
Positive
2691.00
Price Trends
3595.90
Negative
3381.47
Positive
3016.00
Positive
Market Momentum
-57.79
Negative
49.16
Neutral
85.48
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6823, the sentiment is Positive. The current price of 2691 is below the 20-day moving average (MA) of 3413.50, below the 50-day MA of 3595.90, and below the 200-day MA of 3016.00, indicating a neutral trend. The MACD of -57.79 indicates Negative momentum. The RSI at 49.16 is Neutral, neither overbought nor oversold. The STOCH value of 85.48 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6823.
Rion Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥41.06B | 11.94 | ― | 2.93% | 2.15% | 12.47% | |
78 Outperform | ¥17.10B | 12.92 | ― | 3.02% | 13.43% | 7.14% | |
63 Neutral | ¥260.75B | 17.82 | ― | 1.92% | 4.29% | 3.92% | |
58 Neutral | ¥140.05B | 285.71 | 0.33% | 3.73% | 0.78% | -95.37% | |
57 Neutral | ¥70.91B | 19.95 | ― | 2.28% | 2.94% | 57.05% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
54 Neutral | ¥22.70B | -102.99 | ― | 3.12% | -6.64% | 67.08% |
* General Sector Average
JP:6823
Rion Co., Ltd.
3,450.00
849.14
32.65%
JP:6523
PHC Holdings Corp.
1,311.00
365.34
38.63%
JP:4549
Eiken Chemical Co., Ltd.
2,216.00
-52.25
-2.30%
JP:6678
Techno Medica Co., Ltd.
2,116.00
235.90
12.55%
JP:6849
Nihon Kohden Corporation
1,434.50
-246.64
-14.67%
JP:7600
Japan Medical Dynamic Marketing, Inc.
920.00
391.97
74.23%
Rion Co., Ltd. Corporate Events
Rion Posts Strong Q1 Earnings and Confirms Outlook as Dividend Rises
Jul 30, 2026
Rion Co., Ltd. reported consolidated net sales of ¥6,885 million for the three months ended June 30, 2026, up 3.9% year on year, with operating profit rising 19.2% to ¥988 million and profit attributable to owners of parent increasing 15...
Rion Issues Restricted Stock to Directors to Strengthen Long‑Term Governance Alignment
Jul 21, 2026
Rion Co., Ltd. has approved the issuance of 7,900 new common shares as restricted stock compensation to four internal directors, with a total value of 27,176,000 yen and an issue price of 3,440 yen per share, to be paid on August 14, 2026. The pro...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.